CILEX cefalexin 500mg capsule blister pack

Land: Australien

Sprache: Englisch

Quelle: Department of Health (Therapeutic Goods Administration)

Wirkstoff:

cefalexin monohydrate (Equivalent: cefalexin, Qty 500 mg)

Verfügbar ab:

Medis Pharma Pty Ltd

Darreichungsform:

Capsule, hard

Zusammensetzung:

Excipient Ingredients: lactose monohydrate; magnesium stearate; Gelatin; patent blue V; quinoline yellow; titanium dioxide; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; purified water; Shellac; strong ammonia solution; iron oxide black; potassium hydroxide

Verabreichungsweg:

Oral

Einheiten im Paket:

20 capsules

Verschreibungstyp:

(S4) Prescription Only Medicine

Anwendungsgebiete:

Treatment of the following bacterial infections when caused by susceptible strains of the designated micro-organisms. Respiratory tract infections; Strep. pneumoniae and group A B-haemolytic streptococci. Although penicillin is the usual drug of choice in the treatment and prevention of streptococcal infections (including the prophylaxis of rheumatic fever), cephalexin is generally effective in the eradication of streptococci from the nasopharynx. Substantial data establishing the efficacy of cephalexin in the subsequent prevention of rheumatic fever are not available at present. Bacterial sinusitis: Streptococci, Strep. pneumoniae and Staph. aureus (methicillin sensitive only). Otitis media: Strep. pneumoniae, staphylococci (methicillin sensitive only). Skin and skin structure infections: Staphylococci (methicillin sensitive only) and/or streptococci. Genitourinary tract infections, including acute prostatitis: E.coli, P.mirabilis, and Klebsiella sp. The effectiveness of cephalexin in the treatment of bacterial infections of the brain and spinal column has not been established and CILEX is not indicated in these conditions. Note. Appropriate culture and susceptibility tests should be initiated prior to and during therapy to determine susceptibility of the causative organism to CILEX. Renal function studies should be performed when indicated.

Produktbesonderheiten:

Visual Identification: Dark green/light green, hard gelatin, self locked Size 0 capsule, imprinted with two parallel black lines on both the cap & body, containing white to off-white granular powder/pellet.; Container Type: Blister Pack; Container Life Time: 2 Years; Container Temperature: Store below 25 degrees Celsius

Berechtigungsstatus:

Licence status A

Berechtigungsdatum:

1999-04-16